Concepedia

Marked Alteration of Rosuvastatin Pharmacokinetics in Healthy Chinese with ABCG2 34G>A and 421C>A Homozygote or Compound Heterozygote

Zirui Wan, Guo Wang, Tailin Li, Biaobo Xu, Qi Pei, Yan Peng, Hong Sun, Lijuan Cheng, Ying Zeng, Guoping Yang,

Journal of Pharmacology and Experimental Therapeutics · 2015 · 50 citations · 21 references

DOI

Concepts

References

21

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR**STELLAR = Statin Therapies for Elevated Lipid Levels compared Across doses to Rosuvastatin. Trial)

Peter H. Jones, Michael H. Davidson, Evan A. Stein et al. · The American Journal of Cardiology · 2003 · 1.4K citations

, , +14

Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics of Atorvastatin and Rosuvastatin

Marja K. Pasanen, Hanna Fredrikson, Pertti J. Neuvonen et al. · Clinical Pharmacology & Therapeutics · 2007 · 431 citations

, , +13

ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin

Jenni E. Keskitalo, Oliver Zolk, Martin F. Fromm et al. · Clinical Pharmacology & Therapeutics · 2009 · 415 citations

, , +16

Involvement of Multiple Transporters in the Hepatobiliary Transport of Rosuvastatin

Satoshi Kitamura, Kazuya Maeda, Yi Wang et al. · Drug Metabolism and Disposition · 2008 · 355 citations

, , +13

Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2

Shinji Mizuarai, Naohiko Aozasa, Hidehito Kotani · International Journal of Cancer · 2003 · 317 citations

, , +17